Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ANDA Approvals, Submissions Decline With New Review Goal Coming

Executive Summary

Is a rush of generic applications seeking the 10-month clock on the way?


Related Content

ANDA Approvals, Complete Responses Hit Record In FY 2016
FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs
GDUFA II: ANDAs, Not Facilities Will Govern Revenue
ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal
GDUFA II Will Include Small Business Relief, Priority ANDA Reviews
ANDA User Fees Offer Sponsor Relief, But More Facility Pain
ANDA Approval Speed-Up Leaves Sponsors With Less Margin For Error
ANDA Reviews: First-Cycle Desired, But Two-Cycles OK?
ANDA Submission Lull Is Now A Trend, As Are Sluggish Approval Numbers
GDUFA Performance Goals For Fiscal Years 2013-2017